Notice of Results

RNS Number : 0108C

Omega Diagnostics Group PLC

16 June 2021

 

OMEGA DIAGNOSTICS GROUP PLC

("Omega" or the "Company" or the "Group")

Notice of results

Investor presentation

Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance, will issue its financial results for the year ended 31 March 2021 on Tuesday 13 July 2021.

Investor meeting

Colin King and Kieron Harbinson will provide a live presentation relating to the Company's Final Results via the Investor Meet Company platform on Tuesday 13 July 2021 at 4:30pm BST.

The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation.

Investors can sign up to Investor Meet Company for free and add to meet OMEGA DIAGNOSTICS GROUP PLC via:

https://www.investormeetcompany.com/omega-diagnostics-group-plc/register-investor  

Investors who already follow OMEGA DIAGNOSTICS GROUP PLC on the Investor Meet Company platform will automatically be invited.

  Contacts: 

Omega Diagnostics Group PLC	www.omegadiagnostics.com
Colin King, Chief Executive	via Walbrook PR
Kieron Harbinson, Group Finance Director
finnCap Ltd	Tel: [phone]
Geoff Nash/Edward Whiley (Corporate Finance)
Alice Lane (ECM)
Walbrook PR Limited	Tel: [phone] or [e-mail]
Paul McManus	Mob: [phone]
Lianne Cawthorne	Mob: [phone]

 

END

 

 

NORGZGMVNKMGMZM